Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions.

Authors:
Herger N; Heggli I; Mengis T; Devan J; Arpesella L and 3 more

Journal:
Stem Cell Res Ther

Publication Year: 2024

DOI:
10.1186/s13287-024-03677-5

PMCID:
PMC10916130

PMID:
38443999

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Stem Cell Res Ther

Detailed journal information not available.

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Declarations Ethics approval and consent to participateAll study participants provided informed written consent prior to study enrollment. The study was conducted in accordance with the declaration of Helsinki and approved by the ethics commission of the Canton of Zurich, Switzerland. Project title: Biomarker zur Diagnostik, Behandlung und Prädikation der Verläufe der systemischen Sklerose. Ethical approval number: BASEC-Nr. 2018 − 01873. Approval date: October 30, 2018. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Funding Disclosure

Evidence found in paper:

"Funding This work received funding from the USZ Innovation Pool."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025